Analystreport

Agios Pharmaceuticals Inc (NASDAQ: AGIO) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview